Sumatriptan 50 mg

DRUG4 trials

Sponsors

GlaxoSmithKline, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Danish Headache Center

Conditions

MigraineMigraine DisordersMigraine With or Without Aura

Phase 3

Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents

CompletedNCT00963937

GlaxoSmithKlineMigraine Disorders

Start: 2009-09-28End: 2010-12-03Updated: 2018-08-06

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

CompletedNCT01986088

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Migraine With or Without Aura

Start: 1996-11-30End: 1998-01-31Updated: 2021-01-28

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

CompletedNCT01986270

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Migraine With or Without Aura

Start: 1996-12-31End: 1998-01-31Updated: 2021-01-28

Unknown Phase

The Effect of Sumatriptan and Placebo on CGRP Induced Headache

CompletedNCT03542357

Danish Headache CenterMigraine

Start: 2018-02-15End: 2018-09-01Updated: 2019-09-12